As of January 2026 Kiniksa Pharmaceuticals has a market cap of S$4.16 Billion. This makes Kiniksa Pharmaceuticals the world's 3860th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 9th, 2026 the market cap of Kiniksa Pharmaceuticals was reported to be: